Literature DB >> 32729511

Force-dependent trans-endocytosis by breast cancer cells depletes costimulatory receptor CD80 and attenuates T cell activation.

Seungman Park1, Yu Shi2, Byoung Choul Kim3, Myung Hyun Jo4, Leilani O Cruz5, Zheming Gou6, Taekjip Ha7, Li-Fan Lu5, Daniel H Reich2, Yun Chen8.   

Abstract

In this study, we investigated the biophysical interaction between cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and CD80. CTLA-4 is a key molecule in immunosuppression, and CD80 is a costimulatory receptor promoting T cell activation. We observed that after cell-cell contact was established between breast cancer cells and antigen presenting cells (APCs), CTLA-4 expressed on the breast cancer cells bind to CD80 expressed on the APCs, and underwent trans-endocytosis to deplete CD80. Force measurement and live cell imaging revealed that upon binding to CD80, forces generated by breast cancer cells and transmitted via CTLA-4 were sufficiently strong to displace CD80 from the surface of APCs to be internalized by breast cancer cells. We further demonstrated that because of the force-dependent trans-endocytosis of CD80, the capacity of APCs to activate T cells was significantly attenuated. Furthermore, inhibiting force generation in cancer cells would increase the T cell activating capacity of APCs. Our results provide a possible mechanism behind the immunosuppression commonly seen in breast cancer patients, and may lead to a new strategy to restore anti-tumor immunity by inhibiting pathways of force-generation.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32729511      PMCID: PMC8011575          DOI: 10.1016/j.bios.2020.112389

Source DB:  PubMed          Journal:  Biosens Bioelectron        ISSN: 0956-5663            Impact factor:   10.618


  52 in total

1.  Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-κB, NFAT and AP-1.

Authors:  Sabrina Jutz; Judith Leitner; Klaus Schmetterer; Iago Doel-Perez; Otto Majdic; Katharina Grabmeier-Pfistershammer; Wolfgang Paster; Johannes B Huppa; Peter Steinberger
Journal:  J Immunol Methods       Date:  2016-01-15       Impact factor: 2.303

2.  Magnetic microposts as an approach to apply forces to living cells.

Authors:  Nathan J Sniadecki; Alexandre Anguelouch; Michael T Yang; Corinne M Lamb; Zhijun Liu; Stuart B Kirschner; Yaohua Liu; Daniel H Reich; Christopher S Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-05       Impact factor: 11.205

Review 3.  Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.

Authors:  Padmanee Sharma; Siwen Hu-Lieskovan; Jennifer A Wargo; Antoni Ribas
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

4.  The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses.

Authors:  Lucy S K Walker; David M Sansom
Journal:  Nat Rev Immunol       Date:  2011-11-25       Impact factor: 53.106

Review 5.  T-cell regulation by CD28 and CTLA-4.

Authors:  M L Alegre; K A Frauwirth; C B Thompson
Journal:  Nat Rev Immunol       Date:  2001-12       Impact factor: 53.106

6.  CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells.

Authors:  Maria Pia Pistillo; Pier Luigi Tazzari; Giulio Lelio Palmisano; Ivana Pierri; Andrea Bolognesi; Francesca Ferlito; Paolo Capanni; Letizia Polito; Marina Ratta; Stefano Pileri; Milena Piccioli; Giuseppe Basso; Laura Rissotto; Roberto Conte; Marco Gobbi; Fiorenzo Stirpe; Giovanni Battista Ferrara
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

7.  3D Traction forces in cancer cell invasion.

Authors:  Thorsten M Koch; Stefan Münster; Navid Bonakdar; James P Butler; Ben Fabry
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

8.  T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T cells.

Authors:  Judith Leitner; Werner Kuschei; Katharina Grabmeier-Pfistershammer; Ramona Woitek; Ernst Kriehuber; Otto Majdic; Gerhard Zlabinger; Winfried F Pickl; Peter Steinberger
Journal:  J Immunol Methods       Date:  2010-09-19       Impact factor: 2.303

9.  Constructing modular and universal single molecule tension sensor using protein G to study mechano-sensitive receptors.

Authors:  Xuefeng Wang; Zainab Rahil; Isaac T S Li; Farhan Chowdhury; Deborah E Leckband; Yann R Chemla; Taekjip Ha
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

10.  Integrin-mediated traction force enhances paxillin molecular associations and adhesion dynamics that increase the invasiveness of tumor cells into a three-dimensional extracellular matrix.

Authors:  Armen H Mekhdjian; FuiBoon Kai; Matthew G Rubashkin; Louis S Prahl; Laralynne M Przybyla; Alexandra L McGregor; Emily S Bell; J Matthew Barnes; Christopher C DuFort; Guanqing Ou; Alice C Chang; Luke Cassereau; Steven J Tan; Michael W Pickup; Jonathan N Lakins; Xin Ye; Michael W Davidson; Jan Lammerding; David J Odde; Alexander R Dunn; Valerie M Weaver
Journal:  Mol Biol Cell       Date:  2017-04-05       Impact factor: 4.138

View more
  3 in total

Review 1.  Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects.

Authors:  Azam Bozorgi; Maryam Bozorgi; Mozafar Khazaei
Journal:  Cell Oncol (Dordr)       Date:  2022-08-09       Impact factor: 7.051

Review 2.  Recent developments in DNA-based mechanical nanodevices.

Authors:  Qian Tian; Puspam Keshri; Mingxu You
Journal:  Chem Commun (Camb)       Date:  2022-04-12       Impact factor: 6.222

Review 3.  Physical-Chemical Regulation of Membrane Receptors Dynamics in Viral Invasion and Immune Defense.

Authors:  Rui Qin; Chenyi An; Wei Chen
Journal:  J Mol Biol       Date:  2022-08-22       Impact factor: 6.151

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.